5Jan de Beur SM,Levine MA.Molecular pathogenesis of hypophosphatemic rickets.J Clin Endocrinol Metab,2002,87:2467-2473. 被引量：1
6Razzaque MS,Lanske B.The emerging role of the fihrohlast growth factor-23-klotho axis in renal regulation of phosphate homeostasis.J Encdocrinol,2007,194:1-10. 被引量：1
7Weidner N,Santa Cruz D.Phosphaturic mesenchymal tumors.A polymorphous group causing osteomalacia or rickets.Cancer,1987,59:1442-1454. 被引量：1
8Folpe AL,Fanburg-Smith JC,Billings SD,et al.Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity:an analysis of 32 cases and a comprehensive review of the literature.Am J Surg Pathol,2004,28:1-30. 被引量：1
9Imel EA,Peacock M,Pitukcheewanont P,et al.Sensitivity of fibroblast growth factor 23 measurements in tumor-induced osteomalacia.J Clin Endocrinol Metab,2006,91:2055-2061. 被引量：1
10Koriyama N,Nishimoto K,Kodama T,et al.Oncogenic osteomalacia in a case with a maxillary sinus mesenchymal tumor.Am J Med Sci,2006,332:142-147. 被引量：1
